These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2532813)

  • 21. Dissociated antibody responses to the S and pre-S2 regions of the hepatitis B virus after vaccination in hemophiliacs.
    Zanetti A; Tanzi E; Mannucci PM
    J Med Virol; 1989 Jul; 28(3):156-8. PubMed ID: 2526861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Impact of different adjuvants on immunogenicity of the HBV particle vaccine containing the S + preS1 fusion antigen in Balb/C mice].
    Chen H; Deng Y; Tan W; Wang W; Yin X; Guan J; Wang W; Ruan L
    Sheng Wu Gong Cheng Xue Bao; 2010 Jan; 26(1):74-8. PubMed ID: 20353095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Physicochemical and immunological characterization of hepatitis B virus envelope particles exclusively consisting of the entire L (pre-S1 + pre-S2 + S) protein.
    Yamada T; Iwabuki H; Kanno T; Tanaka H; Kawai T; Fukuda H; Kondo A; Seno M; Tanizawa K; Kuroda S
    Vaccine; 2001 Apr; 19(23-24):3154-63. PubMed ID: 11312011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of B and T-cell responses in chimpanzees immunized with Hepagene, a hepatitis B vaccine containing pre-S1, pre-S2 gene products.
    Pride MW; Bailey CR; Muchmore E; Thanavala Y
    Vaccine; 1998 Apr; 16(6):543-50. PubMed ID: 9569463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The safety and immunogenicity of a recombinant hepatitis B vaccine in neonates.
    Gunn TR; Bosley A; Woodfield DG
    N Z Med J; 1989 Jan; 102(860):1-3. PubMed ID: 2521527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and immunogenicity of a novel mammalian cell-derived recombinant hepatitis B vaccine containing Pre-S1 and Pre-S2 antigens in children.
    Raz R; Dagan R; Gallil A; Brill G; Kassis I; Koren R
    Vaccine; 1996 Feb; 14(3):207-11. PubMed ID: 8920701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Persistence of antibodies after immunization with a recombinant yeast-derived hepatitis B vaccine following two different schedules.
    Scheiermann N; Gesemann M; Maurer C; Just M; Berger R
    Vaccine; 1990 Mar; 8 Suppl():S44-6; discussion S60-2. PubMed ID: 2139282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis B virus vaccination for older adults.
    Bennett RG; Powers DC; Remsburg RE; Scheve A; Clements ML
    J Am Geriatr Soc; 1996 Jun; 44(6):699-703. PubMed ID: 8642163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody response to preS1 in hepatitis-B-virus-induced liver disease and after immunization.
    Coursaget P; Buisson Y; Bourdil C; Yvonnet B; Molinié C; Diop MT; Chiron JP; Bao O; Diop-Mar I
    Res Virol; 1990; 141(5):563-70. PubMed ID: 2148981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Properties of recombinant hepatitis B vaccine.
    Ohmura T; Ohmizu A; Sumi A; Ohtani W; Uemura Y; Arimura H; Nishida M; Kohama Y; Okabe M; Mimura T
    Biochem Biophys Res Commun; 1987 Dec; 149(3):1172-8. PubMed ID: 2962578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant Semliki Forest virus vectors encoding hepatitis B virus small surface and pre-S1 antigens induce broadly reactive neutralizing antibodies.
    Niedre-Otomere B; Bogdanova A; Skrastina D; Zajakina A; Bruvere R; Ose V; Gerlich WH; Garoff H; Pumpens P; Glebe D; Kozlovska T
    J Viral Hepat; 2012 Sep; 19(9):664-73. PubMed ID: 22863271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative immunogenicity in children of mammalian cell-derived recombinant hepatitis B vaccine and plasma-derived hepatitis B vaccine.
    Coursaget P; Bringer L; Sarr G; Bourdil C; Fritzell B; Blondeau C; Yvonnet B; Chiron JP; Jeannée E; Guindo S
    Vaccine; 1992; 10(6):379-82. PubMed ID: 1534640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel, recombinant triple antigen hepatitis B vaccine (Hepacare).
    Page M; Jones CD; Bailey C
    Intervirology; 2001; 44(2-3):88-97. PubMed ID: 11509870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-pre-S(2) analysis after hepatitis B vaccination in haemodialysis patients.
    Heijtink RA; de Wilde GA; Kruining J; Smit-Leijs MB; Schalm SW
    Antiviral Res; 1989 Sep; 12(2):75-86. PubMed ID: 2531990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of a robust T- and B-cell immune response in non- and low-responders to conventional vaccination against hepatitis B by using a third generation PreS/S vaccine.
    Krawczyk A; Ludwig C; Jochum C; Fiedler M; Heinemann FM; Shouval D; Roggendorf M; Roggendorf H; Lindemann M
    Vaccine; 2014 Sep; 32(39):5077-82. PubMed ID: 24975813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant DNA hepatitis B vaccine containing Pre-S components of the HBV coat protein--a preliminary study on immunogenicity.
    Yap I; Guan R; Chan SH
    Vaccine; 1992; 10(7):439-42. PubMed ID: 1535170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the immunogenicity of a recombinant vaccine against hepatitis B containing S and pre-S2 sequences using two different schedules.
    Gizaris V; Roumeliotou A; Ktenas E; Papoutsakis G; Papaevangelou G
    Vaccine; 1993 Nov; 11(14):1445-7. PubMed ID: 8310765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunogenicity of the gene S and Pre-S domains in hepatitis B virions and HBsAg filaments.
    Heermann KH; Kruse F; Seifer M; Gerlich WH
    Intervirology; 1987; 28(1):14-25. PubMed ID: 2448264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Algammulin (gamma inulin/alum hybrid adjuvant) has greater adjuvanticity than alum for hepatitis B surface antigen in mice.
    Cooper PD; Turner R; McGovern J
    Immunol Lett; 1991 Feb; 27(2):131-4. PubMed ID: 1827427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HLA linked immune response to S and pre-S2 gene products in hepatitis B vaccination.
    Marescot MR; Budkowska A; Pillot J; Debre P
    Tissue Antigens; 1989 May; 33(5):495-500. PubMed ID: 2477913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.